Saleem Al Mawed1, Mark Unruh. 1. Department of Internal Medicine, Nephrology Division, University of New Mexico, Albuquerque, New Mexico, USA.
Abstract
PURPOSE OF REVIEW: Obstructive sleep apnea (OSA) has been shown to be an independent risk factor for the development and progression of diabetes mellitus. Interestingly, there is also a strong correlation between OSA and the development and progression of chronic kidney disease (CKD). As diabetes mellitus is the most common cause of CKD, in this review we summarize the current literature regarding this interconnecting relationship between OSA, CKD, and diabetes mellitus. The literature increasingly supports a bidirectional relationship between CKD and OSA among diabetes mellitus patients leading to an increased rate of progression of diabetic nephropathy. RECENT FINDINGS: There is growing evidence that among patients with diabetes mellitus, OSA may be a strong risk factor for the development of diabetic nephropathy. The treatment of OSA in CKD patients may play a role in attenuating the rate of the progression of CKD. SUMMARY: Clinicians should have a low threshold for evaluating diabetic patients with CKD for OSA. Further studies examining if treatment of OSA would improve the outcomes of CKD patients in general and diabetic CKD patients in particular are needed.
PURPOSE OF REVIEW: Obstructive sleep apnea (OSA) has been shown to be an independent risk factor for the development and progression of diabetes mellitus. Interestingly, there is also a strong correlation between OSA and the development and progression of chronic kidney disease (CKD). As diabetes mellitus is the most common cause of CKD, in this review we summarize the current literature regarding this interconnecting relationship between OSA, CKD, and diabetes mellitus. The literature increasingly supports a bidirectional relationship between CKD and OSA among diabetes mellituspatients leading to an increased rate of progression of diabetic nephropathy. RECENT FINDINGS: There is growing evidence that among patients with diabetes mellitus, OSA may be a strong risk factor for the development of diabetic nephropathy. The treatment of OSA in CKDpatients may play a role in attenuating the rate of the progression of CKD. SUMMARY: Clinicians should have a low threshold for evaluating diabeticpatients with CKD for OSA. Further studies examining if treatment of OSA would improve the outcomes of CKDpatients in general and diabetic CKDpatients in particular are needed.
Authors: Ester Zamarrón; Ana Jaureguizar; Aldara García-Sánchez; Trinidad Díaz-Cambriles; Alberto Alonso-Fernández; Vanesa Lores; Olga Mediano; Paula Rodríguez-Rodríguez; Sheila Cabello-Pelegrín; Enrique Morales-Ruíz; María T Ramírez-Prieto; María Isabel Valiente-Díaz; Teresa Gómez-García; Francisco García-Río Journal: Sci Rep Date: 2021-03-11 Impact factor: 4.379
Authors: Ian J Neeland; Bjorn Eliasson; Takatoshi Kasai; Nikolaus Marx; Bernard Zinman; Silvio E Inzucchi; Christoph Wanner; Isabella Zwiener; Brian S Wojeck; Henry K Yaggi; Odd Erik Johansen Journal: Diabetes Care Date: 2020-10-01 Impact factor: 19.112